查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591929

基於水凝膠的藥物傳輸系統市場：按輸送途徑、聚合物來源分類 - 2025-2030 年全球預測

Hydrogel-based Drug Delivery System Market by Delivery Route (Ocular, Oral Cavity, Subcutaneous), Polymer Origin (Hybrid, Natural, Synthetic) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年水凝膠給藥系統市值為75.1億美元，預計2024年將達到81.5億美元，複合年成長率為8.65%，到2030年將達到134億美元，預計將達到2000萬美元。

我們的以水凝膠為基礎的藥物傳遞系統系列包括創新的藥物管理方法，利用水凝膠的生物相容性和高含水量來促進受控和持續的藥物釋放。這些系統至關重要，因為它們透過最佳化藥物分佈來提高治療效果、減少副作用並提高患者的依從性。基於水凝膠的藥物遞送技術的應用涵蓋經皮吸收貼片、眼科系統、口服遞送和植入裝置等多個領域，對於針對癌症、糖尿病和自體免疫疾病的藥物我們是相容的。對於最終用途，這些系統主要由製藥公司、研究機構和醫院使用。

主要市場統計
基準年[2023] 75.1億美元
預測年份 [2024] 81.5億美元
預測年份 [2030] 134.2億美元
複合年成長率（%） 8.65%

市場成長受到慢性病盛行率增加、水凝膠技術進步以及對標靶藥物傳遞方法的需求增加等因素的顯著影響。該領域的主要商機包括生物技術和材料科學的持續進步，以開發個人化醫療選擇並擴大在基因和蛋白質治療方面的應用。市場參與者可以透過關注能夠響應溫度和 pH 值等環境刺激的智慧水凝膠並投資於增強水凝膠性能的研究來抓住這些機會。

然而，高昂的開發成本、監管障礙和潛在的生物相容性問題等挑戰是市場擴張的障礙。應對這些挑戰需要與監管機構進行策略合作，以簡化核准流程並進行嚴格的研究和開發，以確保安全性和有效性。最佳創新領域包括探索生物可吸收水凝膠和多模態載藥水凝膠，以實現治療應用多樣化。

市場是動態的，其特點是競爭格局、不斷的技術創新和激烈的研發活動。尋求發展業務的公司正在尋求技術交流和研究合作的合作夥伴，同時緊跟新趨勢，例如使用水凝膠基質進行 3D 生物列印，並投資於強力的臨床試驗來檢驗新應用。

市場動態：快速發展的水凝膠給藥系統市場的關鍵市場洞察

基於水凝膠的藥物傳輸系統市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對標靶控制藥物輸送 (TCDD) 的需求不斷成長
    • 水凝膠因其優異的物理特性
  • 市場限制因素
    • 機械強度低，相容性問題
  • 市場機會
    • 各大製藥公司加大對研發活動的投入與資助
    • 藥品生產中需要提高生物相容性和生物分解性的技術
  • 市場挑戰
    • 水凝膠高成本

波特五力：駕馭水凝膠給藥系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對水凝膠給藥系統市場的外部影響

外部宏觀環境因素在塑造水凝膠給藥系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解水凝膠給藥系統市場的競爭格局

對基於水凝膠的藥物傳輸系統市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣水凝膠給藥系統市場供應商的績效評估

FPNV定位矩陣是評估水凝膠給藥系統市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃水凝膠給藥系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基於水凝膠的藥物傳輸系統市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對標靶控制藥物輸送 (TCDD) 的需求不斷增加
      • 水凝膠具有優異的物理性能
    • 抑制因素
      • 機械強度低和相容性問題
    • 機會
      • 各大製藥公司加大對研發活動的投入與資助
      • 藥品製造中需要改進的生物相容性和生物分解性技術
    • 任務
      • 水凝膠高成本
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章以水凝膠為基礎的藥物傳輸系統市場（以輸送路徑）

  • 眼科
  • 口腔
  • 皮下的
  • 話題

第7章以水凝膠為基礎的藥物傳遞系統市場聚合物起源

  • 混合
  • 自然的
  • 合成

第8章美洲水凝膠給藥系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區水凝膠給藥系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲水凝膠給藥系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Akorn, Incorporated
  • Ashland
  • B. Braun Holding GmbH & Co. KG
  • Bausch and Lomb
  • Blairex Laboratories, Inc.
  • Cardinal Health
  • Endo International plc
  • Ferring BV
  • GALDERMA
  • Johnson & Johnson
  • Medline Industries
  • Medtronic
  • Ocular Therapeutix, Inc.
  • Paul Hartmann
  • Smith & Nephew plc.
  • The Cooper Companies
  • Tolmar Pharmaceuticals, Inc
Product Code: MRR-3E7F10ED1C39

The Hydrogel-based Drug Delivery System Market was valued at USD 7.51 billion in 2023, expected to reach USD 8.15 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 13.42 billion by 2030.

The scope of hydrogel-based drug delivery systems encompasses an innovative approach to medication administration, capitalizing on the biocompatibility and high water content of hydrogels to facilitate controlled and sustained drug release. These systems are crucial because they enhance therapeutic efficacy, reduce side effects, and improve patient compliance by optimizing drug distribution. The application of hydrogel-based drug delivery technology spans across diverse areas, including transdermal patches, ocular systems, oral delivery, and implantable devices, catering to pharmaceuticals targeting cancer, diabetes, and autoimmune diseases, among others. In terms of end-use, these systems are predominantly employed by pharmaceutical companies, research institutes, and hospitals.

KEY MARKET STATISTICS
Base Year [2023] USD 7.51 billion
Estimated Year [2024] USD 8.15 billion
Forecast Year [2030] USD 13.42 billion
CAGR (%) 8.65%

Market growth is significantly influenced by factors such as increasing prevalence of chronic diseases, advancements in hydrogel technology, and rising demand for targeted drug delivery methods. Key opportunities in the sector include the development of personalized medicine options and expanding applications in gene and protein therapy, driven by ongoing advancements in biotechnology and material science. Market players can seize these opportunities by investing in research to enhance hydrogel properties, focusing on smart hydrogels that respond to environmental stimuli like temperature and pH.

However, challenges such as the high cost of development, regulatory hurdles, and potential biocompatibility issues pose barriers to market expansion. Addressing these challenges requires strategic collaboration with regulatory bodies to streamline approval processes and rigorous R&D to ensure safety and efficacy. Best areas of innovation include exploring bioresorbable hydrogels and multimodal drug-loaded hydrogels to diversify therapeutic applications.

The market is dynamic, characterized by continuous technological breakthroughs and a competitive landscape with intense R&D activities. Companies aiming for business growth should focus on partnerships and collaborations for technology exchange, while keeping abreast of emerging trends, such as 3D bioprinting with hydrogel matrices and investing in robust clinical trials to validate novel applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hydrogel-based Drug Delivery System Market

The Hydrogel-based Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising upsurge in the need of targeted controlled drug delivery (TCDD)
    • Hydrogel owing to its excellent physical properties
  • Market Restraints
    • Low mechanical strength, and compatibility issues
  • Market Opportunities
    • Increasing investment and funding by leading pharma companies in R&D activities
    • Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
  • Market Challenges
    • High cost of hydrogels

Porter's Five Forces: A Strategic Tool for Navigating the Hydrogel-based Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hydrogel-based Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hydrogel-based Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hydrogel-based Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hydrogel-based Drug Delivery System Market

A detailed market share analysis in the Hydrogel-based Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hydrogel-based Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hydrogel-based Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hydrogel-based Drug Delivery System Market

A strategic analysis of the Hydrogel-based Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hydrogel-based Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Akorn, Incorporated, Ashland, B. Braun Holding GmbH & Co. KG, Bausch and Lomb, Blairex Laboratories, Inc., Cardinal Health, Endo International plc, Ferring B.V., GALDERMA, Johnson & Johnson, Medline Industries, Medtronic, Ocular Therapeutix, Inc., Paul Hartmann, Smith & Nephew plc., The Cooper Companies, and Tolmar Pharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Hydrogel-based Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Delivery Route, market is studied across Ocular, Oral Cavity, Subcutaneous, and Topical.
  • Based on Polymer Origin, market is studied across Hybrid, Natural, and Synthetic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising upsurge in the need of targeted controlled drug delivery (TCDD)
      • 5.1.1.2. Hydrogel owing to its excellent physical properties
    • 5.1.2. Restraints
      • 5.1.2.1. Low mechanical strength, and compatibility issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment and funding by leading pharma companies in R&D activities
      • 5.1.3.2. Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of hydrogels
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hydrogel-based Drug Delivery System Market, by Delivery Route

  • 6.1. Introduction
  • 6.2. Ocular
  • 6.3. Oral Cavity
  • 6.4. Subcutaneous
  • 6.5. Topical

7. Hydrogel-based Drug Delivery System Market, by Polymer Origin

  • 7.1. Introduction
  • 7.2. Hybrid
  • 7.3. Natural
  • 7.4. Synthetic

8. Americas Hydrogel-based Drug Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Hydrogel-based Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Hydrogel-based Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Akorn, Incorporated
  • 3. Ashland
  • 4. B. Braun Holding GmbH & Co. KG
  • 5. Bausch and Lomb
  • 6. Blairex Laboratories, Inc.
  • 7. Cardinal Health
  • 8. Endo International plc
  • 9. Ferring B.V.
  • 10. GALDERMA
  • 11. Johnson & Johnson
  • 12. Medline Industries
  • 13. Medtronic
  • 14. Ocular Therapeutix, Inc.
  • 15. Paul Hartmann
  • 16. Smith & Nephew plc.
  • 17. The Cooper Companies
  • 18. Tolmar Pharmaceuticals, Inc

LIST OF FIGURES

  • FIGURE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL CAVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023